Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Defining the human sperm microtubulome: an integrated genomics approach.

Jumeau F, Chalmel F, Fernandez-Gomez FJ, Carpentier C, Obriot H, Tardivel M, Caillet-Boudin ML, Rigot JM, Rives N, Buée L, Sergeant N, Mitchell V.

Biol Reprod. 2017 Jan 1;96(1):93-106. doi: 10.1095/biolreprod.116.143479.

PMID:
28395323
2.

Regulation of human MAPT gene expression.

Caillet-Boudin ML, Buée L, Sergeant N, Lefebvre B.

Mol Neurodegener. 2015 Jul 14;10:28. doi: 10.1186/s13024-015-0025-8. Review.

3.

Immunodetection of Tau microtubule-associated protein in human sperm and testis.

Sigala J, Jumeau F, Caillet-Boudin ML, Sergeant N, Ballot C, Rigot JM, Marcelli F, Tardivel M, Buée L, Mitchell V.

Asian J Androl. 2014 Nov-Dec;16(6):927-8. doi: 10.4103/1008-682X.136446. No abstract available.

4.

RBFOX1 cooperates with MBNL1 to control splicing in muscle, including events altered in myotonic dystrophy type 1.

Klinck R, Fourrier A, Thibault P, Toutant J, Durand M, Lapointe E, Caillet-Boudin ML, Sergeant N, Gourdon G, Meola G, Furling D, Puymirat J, Chabot B.

PLoS One. 2014 Sep 11;9(9):e107324. doi: 10.1371/journal.pone.0107324. eCollection 2014.

5.

Tau exon 2 responsive elements deregulated in myotonic dystrophy type I are proximal to exon 2 and synergistically regulated by MBNL1 and MBNL2.

Carpentier C, Ghanem D, Fernandez-Gomez FJ, Jumeau F, Philippe JV, Freyermuth F, Labudeck A, Eddarkaoui S, Dhaenens CM, Holt I, Behm-Ansmant I, Marmier-Gourrier N, Branlant C, Charlet-Berguerand N, Marie J, Schraen-Maschke S, Buée L, Sergeant N, Caillet-Boudin ML.

Biochim Biophys Acta. 2014 Apr;1842(4):654-64. doi: 10.1016/j.bbadis.2014.01.004. Epub 2014 Jan 14.

6.

Brain pathology in myotonic dystrophy: when tauopathy meets spliceopathy and RNAopathy.

Caillet-Boudin ML, Fernandez-Gomez FJ, Tran H, Dhaenens CM, Buee L, Sergeant N.

Front Mol Neurosci. 2014 Jan 9;6:57. doi: 10.3389/fnmol.2013.00057. Review.

7.

Tau pathology modulates Pin1 post-translational modifications and may be relevant as biomarker.

Ando K, Dourlen P, Sambo AV, Bretteville A, Bélarbi K, Vingtdeux V, Eddarkaoui S, Drobecq H, Ghestem A, Bégard S, Demey-Thomas E, Melnyk P, Smet C, Lippens G, Maurage CA, Caillet-Boudin ML, Verdier Y, Vinh J, Landrieu I, Galas MC, Blum D, Hamdane M, Sergeant N, Buée L.

Neurobiol Aging. 2013 Mar;34(3):757-69. doi: 10.1016/j.neurobiolaging.2012.08.004. Epub 2012 Aug 25.

PMID:
22926167
8.

Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms.

Tran H, Gourrier N, Lemercier-Neuillet C, Dhaenens CM, Vautrin A, Fernandez-Gomez FJ, Arandel L, Carpentier C, Obriot H, Eddarkaoui S, Delattre L, Van Brussels E, Holt I, Morris GE, Sablonnière B, Buée L, Charlet-Berguerand N, Schraen-Maschke S, Furling D, Behm-Ansmant I, Branlant C, Caillet-Boudin ML, Sergeant N.

J Biol Chem. 2011 May 6;286(18):16435-46. doi: 10.1074/jbc.M110.194928. Epub 2011 Mar 18.

9.

Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.

Dhaenens CM, Tran H, Frandemiche ML, Carpentier C, Schraen-Maschke S, Sistiaga A, Goicoechea M, Eddarkaoui S, Van Brussels E, Obriot H, Labudeck A, Gevaert MH, Fernandez-Gomez F, Charlet-Berguerand N, Deramecourt V, Maurage CA, Buée L, Lopez de Munain A, Sablonnière B, Caillet-Boudin ML, Sergeant N.

Biochim Biophys Acta. 2011 Jul;1812(7):732-42. doi: 10.1016/j.bbadis.2011.03.010. Epub 2011 Mar 23.

10.

[Molecular actors in Alzheimer's disease: which diagnostic and therapeutic consequences?].

Buée L, Blum D, Bombois S, Buée-Scherrer V, Caillet-Boudin ML, Colin M, Deramecourt V, Dhaenens CM, Galas MC, Hamdane M, Humez S, Maurage CA, Pasquier F, Sablonnière B, Schraen-Maschke S, Sergeant N.

Therapie. 2010 Sep-Oct;65(5):401-7. doi: 10.2515/therapie/2010054. Epub 2010 Dec 13. French.

PMID:
21144474
11.

Transcriptional regulation of the human ST6GAL2 gene in cerebral cortex and neuronal cells.

Lehoux S, Groux-Degroote S, Cazet A, Dhaenens CM, Maurage CA, Caillet-Boudin ML, Delannoy P, Krzewinski-Recchi MA.

Glycoconj J. 2010 Jan;27(1):99-114. doi: 10.1007/s10719-009-9260-y. Epub 2009 Sep 19.

PMID:
19768537
12.

Altered splicing of Tau in DM1 is different from the foetal splicing process.

Ghanem D, Tran H, Dhaenens CM, Schraen-Maschke S, Sablonnière B, Buée L, Sergeant N, Caillet-Boudin ML.

FEBS Lett. 2009 Feb 18;583(4):675-9. doi: 10.1016/j.febslet.2008.12.065. Epub 2009 Jan 21.

13.

Tau as a biomarker of neurodegenerative diseases.

Schraen-Maschke S, Sergeant N, Dhaenens CM, Bombois S, Deramecourt V, Caillet-Boudin ML, Pasquier F, Maurage CA, Sablonnière B, Vanmechelen E, Buée L.

Biomark Med. 2008 Aug;2(4):363-84. doi: 10.2217/17520363.2.4.363.

14.

Biochemistry of Tau in Alzheimer's disease and related neurological disorders.

Sergeant N, Bretteville A, Hamdane M, Caillet-Boudin ML, Grognet P, Bombois S, Blum D, Delacourte A, Pasquier F, Vanmechelen E, Schraen-Maschke S, Buée L.

Expert Rev Proteomics. 2008 Apr;5(2):207-24. doi: 10.1586/14789450.5.2.207. Review.

PMID:
18466052
15.

Overexpression of MBNL1 fetal isoforms and modified splicing of Tau in the DM1 brain: two individual consequences of CUG trinucleotide repeats.

Dhaenens CM, Schraen-Maschke S, Tran H, Vingtdeux V, Ghanem D, Leroy O, Delplanque J, Vanbrussel E, Delacourte A, Vermersch P, Maurage CA, Gruffat H, Sergeant A, Mahadevan MS, Ishiura S, Buée L, Cooper TA, Caillet-Boudin ML, Charlet-Berguerand N, Sablonnière B, Sergeant N.

Exp Neurol. 2008 Apr;210(2):467-78. doi: 10.1016/j.expneurol.2007.11.020. Epub 2007 Dec 4.

PMID:
18177861
16.

ETR-3 represses Tau exons 2/3 inclusion, a splicing event abnormally enhanced in myotonic dystrophy type I.

Leroy O, Dhaenens CM, Schraen-Maschke S, Belarbi K, Delacourte A, Andreadis A, Sablonnière B, Buée L, Sergeant N, Caillet-Boudin ML.

J Neurosci Res. 2006 Sep;84(4):852-9.

PMID:
16862542
17.

Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.

Leroy O, Wang J, Maurage CA, Parent M, Cooper T, Buée L, Sergeant N, Andreadis A, Caillet-Boudin ML.

Biochim Biophys Acta. 2006 Apr;1762(4):460-7. Epub 2005 Dec 29.

18.

O-GlcNAc glycosylation and neurological disorders.

Lefebvre T, Caillet-Boudin ML, Buée L, Delacourte A, Michalski JC.

Adv Exp Med Biol. 2003;535:189-202. Review. No abstract available.

PMID:
14714896
19.

Evidence of a balance between phosphorylation and O-GlcNAc glycosylation of Tau proteins--a role in nuclear localization.

Lefebvre T, Ferreira S, Dupont-Wallois L, Bussière T, Dupire MJ, Delacourte A, Michalski JC, Caillet-Boudin ML.

Biochim Biophys Acta. 2003 Jan 20;1619(2):167-76.

PMID:
12527113
20.

O-glycosylation of the nuclear forms of Pax-6 products in quail neuroretina cells.

Lefebvre T, Planque N, Leleu D, Bailly M, Caillet-Boudin ML, Saule S, Michalski JC.

J Cell Biochem. 2002;85(1):208-18.

PMID:
11891864
21.

Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2/D1 cells into postmitotic neurons.

Ferreira S, Dupire MJ, Delacourte A, Najib J, Caillet-Boudin ML.

Exp Neurol. 2000 Dec;166(2):415-21.

PMID:
11085906
22.

Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line.

Lefebvre T, Alonso C, Mahboub S, Dupire MJ, Zanetta JP, Caillet-Boudin ML, Michalski JC.

Biochim Biophys Acta. 1999 Oct 18;1472(1-2):71-81.

PMID:
10572927
23.

Synthesis of apolipoprotein E (ApoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and ApoE.

Soulié C, Mitchell V, Dupont-Wallois L, Chartier-Harlin MC, Beauvillain JC, Delacourte A, Caillet-Boudin ML.

Neurosci Lett. 1999 Apr 16;265(2):147-50.

PMID:
10327190
24.

Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration.

Bussière T, Hof PR, Mailliot C, Brown CD, Caillet-Boudin ML, Perl DP, Buée L, Delacourte A.

Acta Neuropathol. 1999 Mar;97(3):221-30.

PMID:
10090668
25.

Alzheimer-specific epitope of AT100 in transfected cell lines with tau: toward an efficient cell model of tau abnormal phosphorylation.

Mailliot C, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L.

Neurosci Lett. 1998 Oct 9;255(1):13-6.

PMID:
9839715
26.

Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes.

Mailliot C, Sergeant N, Bussière T, Caillet-Boudin ML, Delacourte A, Buée L.

FEBS Lett. 1998 Aug 21;433(3):201-4.

27.

Apolipoprotein E and Tau phosphorylation in human neuroblastoma cells.

Caillet-Boudin ML, Dupont-Wallois L, Soulié C, Delacourte A.

Neurosci Lett. 1998 Jul 3;250(2):83-6.

PMID:
9697924
28.

ApoE synthesis in human neuroblastoma cells.

Dupont-Wallois L, Soulié C, Sergeant N, Wavrant-de Wrieze N, Chartier-Harlin MC, Delacourte A, Caillet-Boudin ML.

Neurobiol Dis. 1997;4(5):356-64.

PMID:
9440124
29.

Induction of a specific tau Alzheimer epitope in SY-5Y neuroblastoma cells.

Caillet-Boudin ML, Delacourte A.

Neuroreport. 1996 Dec 20;8(1):307-10.

PMID:
9051801
30.

Dephosphorylation studies of SKNSH-SY 5Y cell Tau proteins by endogenous phosphatase activity.

Soulié C, Lépagnol J, Delacourte A, Caillet-Boudin ML.

Neurosci Lett. 1996 Mar 15;206(2-3):189-92.

PMID:
8710183
31.

Shift from fetal-type to Alzheimer-type phosphorylated Tau proteins in SKNSH-SY 5Y cells treated with okadaic acid.

Dupont-Wallois L, Sautière PE, Cocquerelle C, Bailleul B, Delacourte A, Caillet-Boudin ML.

FEBS Lett. 1995 Jan 3;357(2):197-201.

32.

[Detection of Alzheimer type pathological epitopes on Tau proteins of neuroblastoma cells after treatment with okadaic acid].

Sautière PE, Caillet-Boudin ML, Wattez A, Buée-Scherrer V, Delacourte A.

C R Acad Sci III. 1993;316(5):533-5. French.

PMID:
7693312
33.

Functional and structural effects of an Ala to Val mutation in the adenovirus serotype 2 fibre.

Caillet-Boudin ML, Lemay P, Boulanger P.

J Mol Biol. 1991 Feb 5;217(3):477-86.

PMID:
1994035
34.

Human adenovirus-host cell interactions: comparative study with members of subgroups B and C.

Defer C, Belin MT, Caillet-Boudin ML, Boulanger P.

J Virol. 1990 Aug;64(8):3661-73.

35.

O-linked GlcNAc in serotype-2 adenovirus fibre.

Caillet-Boudin ML, Strecker G, Michalski JC.

Eur J Biochem. 1989 Sep 1;184(1):205-11.

36.

Complementary peptide sequences in partner proteins of the adenovirus capsid.

Caillet-Boudin ML.

J Mol Biol. 1989 Jul 5;208(1):195-8.

PMID:
2769752
37.

Structural study of adenovirus type 2 fibre using anti-fibre and anti-peptide sera.

Caillet-Boudin ML, Novelli A, Gesquière JC, Lemay P.

Ann Inst Pasteur Virol. 1988 Apr-Jun;139(2):141-56.

PMID:
3155400
38.

Crystallization, enzymatic cleavage, and the polarity of the adenovirus type 2 fiber.

Devaux C, Caillet-Boudin ML, Jacrot B, Boulanger P.

Virology. 1987 Nov;161(1):121-8.

PMID:
3314115

Supplemental Content

Loading ...
Support Center